Oxford Textbook of Medical Mycology

Christopher C. Kibbler, Professor of Medical Microbiology, University College London, London,Richard Barton, Prinicipal Clinical Scientist, Mycology Reference Centre, Leeds General Infirmary, Leeds,Neil Gow, Chair in Microbiology, Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen,Susan Howell, Head of St John's Dermatology Mycology, Viapath, London,Donna MacCallum, Senior Lecturer, Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen,Rohini Manuel, Consultant Clinical Microbiologist, Public Health Laboratory London, National Infection Service, Public Health England

Christopher C. Kibbler is Professor of Medical Microbiology at University College London and medical mycology is the focus of his academic interests. He has published more than 200 papers, articles, chapters and books and contributed to a number of international guidelines on the management of fungal disease. He is Past President of the British Society of Medical Mycology (BSMM), Past Chair of the UK Clinical Mycology Network and Programme Director of the UCL/BSMM Masters Programme in Medical Mycology.

Richard Barton is a principal clinical scientist and is responsible for running and developing the Mycology Reference Centre in Leeds an NHS mycology diagnostic service provided to health service providers across the UK and beyond. He has published in areas of diagnostic mycology, served on the BSMM executive, and taught at the University of Leeds and for the UCL/BSMM Masters Programme in Medical Mycology.

Neil A. R. Gow is a Professor of Molecular Mycology at the MRC Centre for Medical Mycology at the School of Medicine, Medical Sciences and Nutrition at the Institute of Medical Sciences, University of Aberdeen, Scotland. He is-past- President of the British Mycological Society, the International Society for Human and Animal Mycology (ISHAM) and is current President of the Microbiology Society. He has published extensively on medical and general mycology.

Susan Howell is Head of St John's Dermatology Mycology at Viapath. Her mycological focus is on superficial and subcutaneous fungal infections, and she leads a mycology service that serves patients from the St John's Dermatology clinics, local community and beyond. Susan's academic focus is on teaching and training in order to promote mycology and awareness of fungal infections. She has published a number of papers and book chapters, and is a past Executive Committee member and Secretary to the British Society for Medical Mycology.

Donna M. MacCallum is a Senior Lecturer and Postgraduate Teaching Lead in the School of Medical Sciences at the University of Aberdeen, Scotland. Her academic research in the MRC Centre for Medical Mycology at the University of Aberdeen focuses on infection models to investigate fungal pathogenicity and antifungal therapies, and has published over 70 research papers, reviews and book chapters. She is the current Treasurer of the International Society for Human and Animal Mycoses (ISHAM), past Treasurer of the British Society for Medical Mycology (BSMM) and has served on the eukaryotic Committee of the Microbiology Society.

Rohini J Manuel is a Consultant Microbiologist and Mycology Lead at the Public Health Laboratory London, National Infection Service, Public Health England, as well as a consulting advisor for the Royal College of Pathologists, and member of RCPath England Regional Council. Her main interests are in invasive fungal diseases affecting the immunocompromised. She is a member of the UK Clinical Mycology Network Steering Group, and of the English Surveillance Programme on Antimicrobial Utilisation and Resistance Antifungal Subgroup. She is training lead at the Public Health Laboratory London, Senior Examiner in Medical Microbiology at the Royal College of Pathologists and sits on the Board of Examiners for the British Society for Medical Mycology / UCL MSc in Medical Mycology. Rohini is one of the organisers for the national Fungal Update meeting at St Bartholomewâs Hospital, London. She is a key member of the UK Incident Management Team for the newly emerging global pathogen, Candida auris.

Angela Ahlquist Cleveland, Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
Darius Armstrong James, National Heart and Lung Institute, Imperial College London, UK
H. Ruth Ashbee, School of Molecular and Cellular Biology, University of Leeds, UK
Matthijs Backx, Wales Centre for Mycobacteria (WCM), Public Health Wales Microbiology Cardiff, UK
Rosemary A. Barnes, Infection and Immunity, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, UK
Richard Barton, Mycology Reference Centre, Leeds General Infirmary, Leeds, UK
Tihana Bicanic, Institute for Infection and Immunity, St George's University of London, UK
Andrew M. Borman, Public Health England National UK Mycology Reference Laboratory, Bristol, UK
Rosie E. Bradshaw, Institute of Fundamental Sciences, Massey University, Palmerston North, New Zealand
Mary E. Brandt, Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
Alistair J.P. Brown, The Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, UK
Gordon D. Brown, The Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK
Arunaloke Chakrabarti, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Heather L. Clark, University of California, Irvine, CA, USA
Joanne Cleverley, Royal Free Hospital London, UK
Christopher P. Conlon, Medical Sciences Division, Nuffield Department of Medicine, Oxford, UK
Oliver A. Cornely, Department I of Internal Medicine, University Hospital of Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), and Clinical Trials Centre Cologne, ZKS Koln, University of Cologne, Germany; German Centre for Infection Research, Partner Site Bonn-Cologne, Germany; and Clinical Trials Centre Cologne, ZKS Koln, Germany
Laura Cottom, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK
Manuel Cuenca-Estrella, Instituto de Salud Carlos III, Madrid, Spain
Ivy M. Dambuza, The Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK
Blandine Denis, Service des maladies infectieuses et tropicales, Hopital Saint Louis, AP-HP Paris, France; and UMR S 1136, INSERM et Sorbonne Universites, UPMC Univ Paris 06, Paris, France
David W. Denning, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
Sarah Drake, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK
Paul S. Dyer, School of Life Sciences, University of Nottingham, UK
Angel A. Gonzalez, Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellin, Colombia
Stuart Flanagan, Department of Infection and Immunology, Royal London Hospital, London, UK
Beatriz L. Gomez, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, & Corporacion para Investigaciones Biologicas (CIB), Medellin, Colombia
Neil A.R. Gow, The Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, UK
Catriona L. Halliday, Clinical Mycology Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Pathology West, ICPMR, Westmead Hospital, Westmead, NSW, Australia
Thomas S. Harrison, Institute for Infection and Immunity, St George's University of London, UK
Roderick J. Hay, Skin Infection Clinic, King's College Hospital NHS Trust, Denmark Hill, London, UK
Susan Howell, Head of Laboratory, St John's Institute of Dermatology, Viapath, London, UK
Bernhard Hube, Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoll Institute (HKI), Jena, Germany
Samantha E. Jacobs, Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA
Elizabeth M. Johnson, Public Health England National UK Mycology Reference Laboratory, Bristol, UK
Brian L. Jones, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK
Christopher C. Kibbler, Centre for Medical Microbiology, University College London, UK
Sarah E. Kidd, National Mycology Reference Centre, SA Pathology, Adelaide, SA, Australia
Philipp Koehler, Department I of Internal Medicine, University Hospital of Cologne, Germany; and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), and Clinical Trials Centre Cologne, ZKS Koln, University of Cologne, Germany
Chris Kosmidis, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
Oliver Kurzai, National Reference Center for Invasive Fungal Infections, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoll Institute (HKI), Jena, Germany
Fanny Lanternier, Universite Paris-Descartes, Centre d'Infectiologie Necker-Pasteur, Hopital Necker-Enfants Malades, Paris, France; and Centre National de Reference Mycoses Invasives et Antifongiques, Unite de Mycologie Moleculaire, Institut Pasteur, Paris, France
Rebecca Lester, Global Medicines Development, AstraZeneca, DE, USA
Russell E. Lewis, Department of Medical Sciences and Surgery, University of Bologna, Italy
Chris Linton, Department of Cellular and Molecular Medicine, Bristol University, Public Health Laboratory, Bristol, UK
Shawn R. Lockhart, Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
Olivier Lortholary, Universite Paris-Descartes, Centre d'Infectiologie Necker-Pasteur, Hopital Necker-Enfants Malades, Paris, France; and Centre National de Reference Mycoses Invasives et Antifongiques, Unite de Mycologie Moleculaire, Institut Pasteur, Paris, France
Sebastian B. Lucas, Department of Histopathology, St Thomas' Hospital, London, UK
Donna M. MacCallum, The Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, UK
Damien Mack, Division of Infection and Immunity, University College London, UK
Rohini J. Manuel, Public Health Laboratory, National Infection Service, Public Health England, UK
Eileen K. Maziarz, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Rajal K. Mody, Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
Eavan G. Muldoon, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
Carol A. Munro, The Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK
Frank C. Odds, The Aberdeen Fungal Group, Aberdeen, UK
Shara Palanivel, Royal Free Hampstead NHS Foundation Trust, London, UK
Michael D. Palmer, Public Health England (PHE) National Mycology Reference Laboratory, Bristol, UK
Eric Pearlman, Case Western Reserve University, Cleveland, OH, USA
John R. Perfect, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Nick D. Read, Manchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, University of Manchester, UK
Anna Reed, Royal Brompton and Harefield NHS Trust, London, UK
Angela Restrepo, Corporacion para Investigaciones Biologicas (CIB), Medellin, Colombia
John Rex, Global Medicines Development, AstraZeneca, DE, USA
Thomas R. Rogers, Department of Clinical Microbiology, Trinity College Dublin, St James's Hospital Campus, Dublin, Ireland
Jonathan Sandoe, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK
Silke Schelenz, Department of Microbiology, Royal Brompton Hospital, London, UK
Shila Seaton, National Infection Service, Public Health England, Colindale, London, UK
Anand Shah, Fungal Disease Immunobiology, Imperial College London, UK
Gillian Shankland, School of Medicine, Dentistry and Nursing, University of Glasgow, UK
Catherine B. Small, Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA
Stephanie Smith, Public Health Laboratory, National Infection Service, Public Health England, UK
Jack D. Sobel, Wayne State University, School of Medicine, Detroit, MI, USA
Jeanette Wagener, The Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK
Thomas J. Walsh, Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA
David W. Warnock, Faculty of Biology, Medicine and Health, University of Manchester, UK
Simon Warren, Royal Free Hampstead NHS Foundation Trust, London, UK
Adilia Warris, The Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, UK
P. Lewis White, Public Health Wales, Microbiology Cardiff, University Hospital of Wales, Cardiff, UK
Duncan Wilson, The Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK